All Research Groups

Picture of Stefan Willför

Valorisation of biomass using molecular process technology

Stefan Willför
swillfor[at]abo.fi

Laboratory of Wood and Paper Chemistry,
Åbo Akademi University

Stefan Willför

PCC

Antibacterial, Biopharmaceuticals, Diagnostics, Drug solubility, Drug stability, Electron microscopy, Hit to lead, MALS or SEC-MALS, Natural Compounds, Natural products, NMR, Organic Chemistry, Organic compounds, Particle size analysis, Personalized medicine, Physico-chemical properties, Porosity, Surface area, Synthetic chemistry, Thermal analysis

Bioorganic Group

Pasi Virta
pamavi[at]utu.fi

Bioorganic chemistry group, Department of Chemistry,
University of Turku

Pasi Virta

Atomic-force microscopy, Cancer, Drug target, Hit to lead, Lead optimization, Medicinal chemistry, Nanoparticles, Neurological disorders, NMR, Nucleic acids, Organic Chemistry, Organic compounds, PET, Synthetic chemistry, Thermal analysis

Radiopharmaceuticals for positron emission tomography (PET) imaging

Xiang-Guo Li
xiali[at]utu.fi

Turku PET Centre,
University of Turku

Xiang-Guo Li

Turku PET Centre

ResearchGate

Antibodies, Assay development, Biomedicine, Cancer, Cardiovascular diseases, Clinical Chemistry, Drug delivery, Drug solubility, Drug stability, Formulation, Imaging, In Vivo Diagnostics, Infection, Inflammation, Medicinal chemistry, Metabolic diseases, Molecular diagnostics, Nanoparticles, Nucleic acids, Organic Chemistry, Organic compounds, Personalized medicine, PET, Pharmacy, Physico-chemical properties, Preclinical development, Synthetic chemistry

Picture of Fang Cheng

Tissues Regeneration and Cancer

Fang Cheng
fang.cheng[at]utu.fi

Turku Bioscience Centre,
University of Turku

Fang Cheng

Tissues Regeneration and Cancer

Assay development, Biomarker, Biomedicine, Biotechnology, Cancer, Colorectal cancer, Disease models, Drug target, High throughput imaging, Imaging, Inflammation, Lead optimization, Metabolic diseases, Molecular Cell Biology, Natural Compounds, Personalized medicine, Screening, Signaling, Skin diseases, Target discovery

Signaling of Receptor Tyrosine Kinases in Cancer and Development

Klaus Elenius
klaele[at]utu.fi

Institute of Biomedicine,
University of Turku

Klaus Elenius

Basic research, Biomarker, Biomedicine, Breast cancer, Cancer, Colorectal cancer, Data mining, Diagnostics, Drug delivery, Drug target, Genomics, Lung cancer, Melanoma, Molecular Cell Biology, Molecular modelling, Next-generation sequencing, Pathology, Personalized medicine, Receptor, Signaling, Squamous cell carcinoma, Target discovery

Glycolipids and glycoproteins as cell adhesion receptors

Sauli Haataja
sauli.haataja[at]utu.fi

Institute of Biomedicine,
University of Turku

Sauli Haataja

Antibacterial, Antibodies, Assay development, Bacteriology, Basic research, Biochemistry, Bioinformatics, Biomedicine, Biomolecular chemistry, Biopharmaceuticals, Biotechnology, Cancer, Electron microscopy, Genetics, Genomics, Imaging, Infection, Inflammation, Molecular Biology, Molecular Cell Biology, Molecular modelling, Nanoparticles, Natural Compounds, Natural products, Next-generation sequencing, Proteomics, Receptor, Screening, Signaling, Structural Biology, Synthetic chemistry, Systems Biology, Target discovery, X-ray crystallography